阿洛酮糖

GI(Glucose = 100)

0^*0^*

Energy(kcal/100g)

40 kcal^*40 kcal^*

Carbs(g/100g)

100 g^*100 g^*

Sugars(g/100g)

0 g^*0 g^*

功能性益處

• 不會促進蛀牙

  FDA labeling guidance: plaque-pH evidence — does not promote dental caries. Not a 21 CFR 101.80 health-claim listing.

  FDA — Declaration of allulose and calories from allulose (guidance) (2020)

• 動物試驗中的 GLP-1 釋放與葡萄糖耐受

  Iwasaki et al. (Nat Commun): oral D-allulose raises GLP-1 and improves glucose tolerance via GLP-1R / vagal afferents in rodents. Display-only mechanism — not a human diabetes or weight-loss drug claim.

  Iwasaki et al. — D-allulose GLP-1 release and vagal afferents (Nat Commun) (2018)

已引述的礦物質可在 日常最適合的甜味劑 上最多加 +2 分，見 Methods。

風險與副作用

• 大劑量可能引起滲透性腸胃不適

  caution

  Largest symptom-free single dose 0.4 g/kg (29 young adults, dose raised weekly); at 0.5 g/kg 13 of 29 had diarrhoea. Daily maximum 0.9 g/kg. An older trial put the symptom-free dose near 0.55 g/kg (Iida 2007, not yet checked); the lower figure is scored. Not a medical diagnosis. Scored: −3 on Everyday Health, Diabetic-friendly and Minimally processed — largest symptom-free single dose 0.4–0.6 g/kg.

  Han et al. — Gastrointestinal tolerance of D-allulose in healthy and young adults. A non-randomized controlled trial (Nutrients) (2018)

這不是醫療建議。若該項目會依公開公式扣分，細節列在「分數怎麼算」；分數不代表臨床嚴重程度。

註記

還沒有額外的背景註記。

註記說明公開軸或風險標籤本身看不出來的事，不是醫療建議。